Bruno Royer
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments 25
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 26
- Nephrology top 2%
-
- Lymphoma Diagnosis and Treatment 14
- Oncology top 5%
- Peptidase Inhibition and Analysis 5
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 22
-
- Immunodeficiency and Autoimmune Disorders 8
-
- Peripheral Neuropathies and Disorders 5
-
- Eosinophilic Disorders and Syndromes 5
- Co-authors
- Jean‐Paul FermandArnaud JaccardJean‐Claude BrouetBertrand ArnulfVéronique LeblondSylvie ChevretXavier MarietteFrank Bridoux
- Cited by
- HematologyGeneticsNephrology
- Journals
- Blood (23 papers)American Journal of Hematology (5 papers)British Journal of Haematology (4 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Bruno Royer
74 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 70
- Hematology 1.1k
- Genetics 741
- Nephrology 249
- Pathology and Forensic Medicine 414
- Oncology 623
Countries citing papers authored by Bruno Royer
This map shows the geographic impact of Bruno Royer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Royer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Royer more than expected).
Fields of papers citing papers by Bruno Royer
This network shows the impact of papers produced by Bruno Royer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Royer. The network helps show where Bruno Royer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bruno Royer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 19 | |
| 5 | 2022 | 21 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 70 | |
| 8 | 2021 | 39 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 29 | |
| 11 | 2015 | 79 | |
| 12 | 2014 | 28 | |
| 13 | 2011 | 33 | |
| 14 | 2010 | 96 | |
| 15 | 2010 | 2 | |
| 16 | 2009 | 7 | |
| 17 | 2006 | 46 | |
| 18 | 2004 | 75 | |
| 19 | Thalidomide et myélome : le renouveau d'un médicament décrié | 2001 | 1 |
| 20 | 2000 | 85 |
About Bruno Royer
Bruno Royer is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Nephrology and Immunology, having authored 84 papers that have together received 2.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (26 papers), Multiple Myeloma Research and Treatments (25 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (22 papers), Lymphoma Diagnosis and Treatment (14 papers), Immunodeficiency and Autoimmune Disorders (8 papers), Peripheral Neuropathies and Disorders (5 papers), Peptidase Inhibition and Analysis (5 papers) and Eosinophilic Disorders and Syndromes (5 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (741 citations), Nephrology (249 citations), Pathology and Forensic Medicine (414 citations) and Oncology (623 citations). Bruno Royer has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Jean‐Paul Fermand, Arnaud Jaccard, Jean‐Claude Brouet, Bertrand Arnulf, Véronique Leblond, Sylvie Chevret, Xavier Mariette, Frank Bridoux, Olivier Hermine and Margaret Macro. Their work appears in journals such as Blood, American Journal of Hematology, British Journal of Haematology, Leukemia and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.